Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study

202029 citationsJournal Articlehybrid Open Access

Authors

NCT02424019.

Good health and well-being

Published in: British Journal of Ophthalmology

Volume 105, Issue 3, pp. 414-419

Field-Weighted Citation Impact: 3.17